Headquartered in Munich, Germany, TomTec’s products and services promise to help clinicians to increase efficiency and diagnostic quality through automated and reproducible measurements. The acquisition will strengthen Philips’ leadership position in cardiac ultrasound, and support the company’s further expansion in other clinical areas, such as obstetrics and gynecology (OB/GYN).
Royal Dutch Philips has a large global installed base in ultrasound solutions and claims a broad and strong portfolio in areas such as real-time 3D imaging of the heart, quantification tools driven by Anatomical Intelligence, and ultra-mobile, portable ultrasound solutions. Philips’ ultrasound portfolio supports the effective and efficient delivery of care across a broad range of clinical specialties including radiology, cardiology, point-of-care and OB/GYN.
Highly complementary addition
TomTec’s clinical applications, workflow solutions and R&D capabilities areto provide a highly complementary addition to Philips’ strengths in ultrasound image quality, 3D-imaging and transducer technology. The German company offers multi-modality and vendor-neutral diagnostic and analysis applications in cardiology, radiology and OB/GYN. Their software is used by more than 20,000 physicians and 600 health facilities worldwide to treat their patients daily.
Founded in 1990, TomTec has a global presence with offices in the U.S., Europe and Asia. Upon completion of the transaction, the business and its over 100 employees will be part of the Philips’ Ultrasound Business Group. In addition to the commercialization of Philips-branded products for clinical automation, workflow improvement and enhanced diagnostic quality, the TomTec business will continue its vendor-neutral product line and integrate these medical software applications into third party systems to support clinical needs and routine workflow.